keyword
https://read.qxmd.com/read/38494526/irreversible-electroporation-to-bring-initially-unresectable-locally-advanced-pancreatic-adenocarcinoma-to-surgery-the-irecap-phase-ii-study
#1
JOURNAL ARTICLE
Jean-Pierre Tasu, Guillaume Herpe, Jérôme Damion, Jean-Pierre Richer, Bertrand Debeane, Mathilde Vionnet, Laetitia Rouleau, Michel Carretier, Aurélie Ferru, Pierre Ingrand, David Tougeron
OBJECTIVES: The aim of the IRECAP study was to evaluate the rate of locally advanced pancreas cancer patients (LAPC) who could undergo R0 or R1 surgery after irreversible electroporation (IRE). MATERIALS AND METHODS: IRECAP study is a phase II, single-center, open-label, prospective, non-randomized trial registered at clinicaltrials.gov (NCT03105921). Patients with LAPC were first treated by 3-month neo-adjuvant chemotherapy in order to avoid inclusion of either patients with LAPC having become resectable after chemotherapy or patients with rapid disease progression...
March 18, 2024: European Radiology
https://read.qxmd.com/read/37695398/new-developments-in-image-guided-percutaneous-irreversible-electroporation-of-solid-tumors
#2
REVIEW
Jung H Yun, Adam Fang, Fereshteh Khorshidi, Peiman Habibollahi, Oleksandra Kutsenko, Vahid Etezadi, Stephen Hunt, Nariman Nezami
PURPOSE OF REVIEW: This review will describe the various applications, benefits, risks, and approaches of conventional irreversible electroporation (IRE), as well as highlight the new technological developments of this procedure along with their clinical applications. RECENT FINDINGS: Minimally invasive image-guided percutaneous IRE ablation has emerged as a newer, non-thermal ablation technique for tumors in the solid organs, particularly within the liver, pancreas, kidney, and prostate...
September 11, 2023: Current Oncology Reports
https://read.qxmd.com/read/37429756/a-mouse-model-for-high-efficient-flp-recombinase-mediated-genetic-manipulation-in-the-pancreas
#3
JOURNAL ARTICLE
Xiaohui Zhu, Jiaxiang Chen, Bin Wang, Lingxiang Wang, Jiale Wang, Dongfeng Feng, Yan Yang, Oliver Wang, Ashley N Haddock, Ying Wang, Baoan Ji, Yan Bi
BACKGROUND: Tissue and cell-specific gene targeting has been widely employed in biomedical research. In the pancreas, the commonly used Cre recombinase recognizes and recombines loxP sites. However, to selectively target different genes in distinct cells, a dual recombinase system is required. METHOD: We developed an alternative recombination system mediated by FLPo, which recognizes frt DNA sequences for pancreatic dual recombinase-mediated genetic manipulation...
June 28, 2023: Pancreatology: Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
https://read.qxmd.com/read/37180371/irreversible-electroporation-of-the-pancreas-a-decade-on
#4
JOURNAL ARTICLE
Daniel Yuxuan Ong, Guo Yuan How, Uei Pua
Irreversible electroporation (IRE) employs the use of an electric field to cause irreversible permeability of the cell membrane, inducing apoptosis. The use of IRE for locally advanced pancreatic cancer (LAPC) was first described in 2012. The crucial advantage of IRE compared with other devices employing thermal ablation is the safety around vital structures such as vessels and ducts. This makes it an attractive option for use in the pancreas due to the close proximity of multiple major vascular structures, biliary ducts, and adjacent gastrointestinal organs...
February 2023: J Interv Med
https://read.qxmd.com/read/37074194/role-of-rna-domain-structure-and-orientation-in-the-coxsackievirus-b3-virulence-phenotype
#5
JOURNAL ARTICLE
Lydia Phillips, William E Tapprich
Coxsackievirus B3 (CVB3) is an enterovirus that causes diseases such as pancreatitis and myocarditis in humans. Approximately 10% of the CVB3 RNA genome consists of a highly structured 5' untranslated region (5' UTR) that is organized into six domains and contains a type I internal ribosome entry site (IRES). These features are common to all enteroviruses. Each RNA domain plays a vital role in translation and replication during the viral multiplication cycle. We used SHAPE-MaP chemistry to generate secondary structures of the 5' UTR from the avirulent strain CVB3/GA and the virulent strain CVB3/28...
April 19, 2023: Journal of Virology
https://read.qxmd.com/read/37072351/irreversible-electroporation-augments-%C3%AE-glucan-induced-trained-innate-immunity-for-the-treatment-of-pancreatic-ductal-adenocarcinoma
#6
JOURNAL ARTICLE
Matthew R Woeste, Rejeena Shrestha, Anne E Geller, Shu Li, Diego Montoya-Durango, Chuanlin Ding, Xiaoling Hu, Hong Li, Aaron Puckett, Robert A Mitchell, Traci Hayat, Min Tan, Yan Li, Kelly M McMasters, Robert C G Martin, Jun Yan
BACKGROUND: Pancreatic cancer (PC) is a challenging diagnosis that is yet to benefit from the advancements in immuno-oncologic treatments. Irreversible electroporation (IRE), a non-thermal method of tumor ablation, is used in treatment of select patients with locally-advanced unresectable PC and has potentiated the effect of certain immunotherapies. Yeast-derived particulate β-glucan induces trained innate immunity and successfully reduces murine PC tumor burden. This study tests the hypothesis that IRE may augment β-glucan induced trained immunity in the treatment of PC...
April 2023: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/36792137/irreversible-electroporation-assisted-resection-for-locally-advanced-pancreas-cancer
#7
JOURNAL ARTICLE
Joshua Mk Davis, Patrick N Salibi, Benjamin M Motz, Dionisios Vrochides, Iain H McKillop, David A Iannitti
BACKGROUND: A significant number of patients with advanced pancreatic cancer are unable to undergo resection due to vascular involvement. Irreversible electroporation (IRE) has shown promise in improving survival. This study sought to assess a novel IRE application whereby IRE was performed pre-resection to alter tissue plasticity and assist tumor removal from underlying vasculature when surgical excision was otherwise precluded. METHODS: After multidisciplinary evaluation appropriate patients were consented for IRE therapy...
February 15, 2023: Surgical Innovation
https://read.qxmd.com/read/36607943/early-single-center-experience-with-irreversible-electroporation-for-stage-2-3-and-4-pancreatic-adenocarcinomas
#8
JOURNAL ARTICLE
Chris Wall, Shahid Ahmed, Rasel Kabir, Hyun J Lim, Mussawar Iqbal, Haji Chalchal, Trustin Domes, Gavin Beck, Yigang Luo, Maurice Ogaick, John Shaw, Michael Moser
OBJECTIVES: Irreversible electroporation (IRE) is an ablation technology that uses electrical energy delivered between electrodes. If the electrodes are placed atraumatically, there is little to no risk of collateral injury, making IRE appealing for the treatment of pancreatic tumors. METHODS: We report on 20 patients with pancreatic adenocarcinoma (PAC) who underwent 21 IRE in our center. There were 6 IRE for stage 2 PAC, 11 for stage 3 PAC, 1 for stage 4 PAC, and 2 patients treated with IRE for recurrence after pancreaticoduodenectomy...
September 1, 2022: Pancreas
https://read.qxmd.com/read/36185275/commentary-the-synergistic-role-of-irreversible-electroporation-and-chemotherapy-for-locally-advanced-pancreatic-cancer
#9
COMMENT
Vincenza Granata, Raffaele Palaia, Francesco Izzo
No abstract text is available yet for this article.
2022: Frontiers in Oncology
https://read.qxmd.com/read/35551086/treatment-of-unresectable-locally-advanced-pancreatic-cancer-with-percutaneous-irreversible-electroporation-ire-following-initial-systemic-chemotherapy-lap-pie-trial-study-protocol-for-a-feasibility-randomised-controlled-trial
#10
JOURNAL ARTICLE
Zainab L Rai, Veronica Ranieri, Daniel H Palmer, Peter Littler, Pauleh Ghaneh, Kurinchi Gurusamy, Derek Manas, Elena Pizzo, Eftychia Eirini Psarelli, Roopinder Gilmore, Praveen Peddu, David C Bartlett, Nicola de Liguori Carino, Brian R Davidson
BACKGROUND: Approximately 30% of patients with pancreas cancer have unresectable locally advanced disease, which is currently treated with systemic chemotherapy. A new treatment option of irreversible electroporation (IRE) has been investigated for these patients since 2005. Cohort studies suggest that IRE confers a survival advantage, but with associated, procedure-related complications. Selection bias may account for improved survival and there have been no prospective randomised trials evaluating the harms and benefits of therapy...
May 12, 2022: BMJ Open
https://read.qxmd.com/read/35372046/exploration-of-novel-pathways-underlying-irreversible-electroporation-induced-anti-tumor-immunity-in-pancreatic-cancer
#11
REVIEW
Khan Mohammad Imran, Margaret A Nagai-Singer, Rebecca M Brock, Nastaran Alinezhadbalalami, Rafael V Davalos, Irving Coy Allen
Advancements in medical sciences and technologies have significantly improved the survival of many cancers; however, pancreatic cancer remains a deadly diagnosis. This malignancy is often diagnosed late in the disease when metastases have already occurred. Additionally, the location of the pancreas near vital organs limits surgical candidacy, the tumor's immunosuppressive environment limits immunotherapy success, and it is highly resistant to radiation and chemotherapy. Hence, clinicians and patients alike need a treatment paradigm that reduces primary tumor burden, activates systemic anti-tumor immunity, and reverses the local immunosuppressive microenvironment to eventually clear distant metastases...
2022: Frontiers in Oncology
https://read.qxmd.com/read/34860812/safety-of-irreversible-electroporation-ablation-of-the-pancreas
#12
JOURNAL ARTICLE
Edward Wolfgang Lee, Puja Shahrouki, Stephanie Peterson, Bashir A Tafti, Peng-Xu Ding, Stephen T Kee
OBJECTIVES: To evaluate the safety of irreversible electroporation (IRE) on swine pancreatic tissue including its effects on peripancreatic vessels, bile ducts, and bowel. METHODS: Eighteen Yorkshire pigs underwent IRE ablation of the pancreas successfully and without clinical complications. Contrast-enhanced computed tomography angiography and laboratory studies before the IRE ablation with follow-up computed tomography angiography, laboratory testing, and pathological examination up to 4 weeks postablation were performed...
October 1, 2021: Pancreas
https://read.qxmd.com/read/34781824/review-of-clinical-tumor-ablation-advance-in-asia
#13
MULTICENTER STUDY
Luo Wang, Jinshun Xu, Jie Yu, Ping Liang
Tumor ablation has been widely applied in Asia, accounting for 44.65% of clinical studies worldwide. We reviewed 5853 clinical studies to provide insight on the advance of tumor ablation in Asia chronologically and geographically among different techniques and organs. Since 1998, tumor ablation application has dramatically evolved in Asia. All kinds of ablation techniques, including percutaneous ethanol injection (PEI), radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), cryoablation (CA), high-intensity focused ultrasound (HIFU), and irreversible electroporation (IRE), have been applied, with the first application of PEI and the most popular application of RFA...
2021: International Journal of Hyperthermia
https://read.qxmd.com/read/34404600/open-irreversible-electroporation-for-isolated-local-recurrence-of-pancreatic-ductal-adenocarcinoma-after-primary-surgery
#14
JOURNAL ARTICLE
Ulrike Heger, Claudia Mack, Christine Tjaden, Feng Pan, Thomas Pausch, Ulf Hinz, Christof M Sommer, Thilo Hackert
BACKGROUND/OBJECTIVES: Irreversible electroporation (IRE) is an emerging treatment for locally advanced pancreatic cancer (LAPC) which in some cohorts has been associated with severe complications. Additionally, re-resection of isolated local recurrence (ILR) after pancreatic ductal adenocarcinoma (PDAC) can improve survival. We investigated safety, feasibility and oncologic outcomes in the first report on open IRE for unresectable ILR of PDAC in a staged surgical approach. METHODS: Records of the prospectively documented institutional database were screened for patients undergoing laparotomy in IRE-standby due to questionable resectability...
October 2021: Pancreatology: Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
https://read.qxmd.com/read/34289060/high-coexpression-of-the-ghrelin-and-leap2-receptor-ghsr-with-pancreatic-polypeptide-in-mouse-and-human-islets
#15
JOURNAL ARTICLE
Deepali Gupta, Georgina K C Dowsett, Bharath K Mani, Kripa Shankar, Sherri Osborne-Lawrence, Nathan P Metzger, Brian Y H Lam, Giles S H Yeo, Jeffrey M Zigman
Islets represent an important site of direct action of the hormone ghrelin, with expression of the ghrelin receptor (growth hormone secretagogue receptor; GHSR) having been localized variably to alpha cells, beta cells, and/or somatostatin (SST)-secreting delta cells. To our knowledge, GHSR expression by pancreatic polypeptide (PP)-expressing gamma cells has not been specifically investigated. Here, histochemical analyses of Ghsr-IRES-Cre × Cre-dependent ROSA26-yellow fluorescent protein (YFP) reporter mice showed 85% of GHSR-expressing islet cells coexpress PP, 50% coexpress SST, and 47% coexpress PP + SST...
October 1, 2021: Endocrinology
https://read.qxmd.com/read/34163121/local-ablation-of-pancreatic-tumors-state-of-the-art-and-future-perspectives
#16
REVIEW
Vincenza Granata, Roberta Grassi, Roberta Fusco, Andrea Belli, Raffaele Palaia, Gianpaolo Carrafiello, Vittorio Miele, Roberto Grassi, Antonella Petrillo, Francesco Izzo
BACKGROUND: Currently, the technologies most commonly used to treat locally advanced pancreatic cancer are radiofrequency ablation (RFA), microwave ablation, and irreversible (IRE) or reversible electroporation combined with low doses of chemotherapeutic drugs. AIM: To report an overview and updates on ablative techniques in pancreatic cancer. METHODS: Several electronic databases were searched. The search covered the years from January 2000 to January 2021...
June 21, 2021: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/33985915/irreversible-electroporation-of-pancreatic-cancer-effect-on-quality-of-life-and-pain-perception
#17
JOURNAL ARTICLE
Rasmus Virenfeldt Flak, Molly Maine Malmberg, Mogens Tornby Stender, Ann Hauberg, Ole Thorlacius-Ussing
BACKGROUND: Most pancreatic cancer (PC) patients are incurable and may need palliative treatment at some point in time. Irreversible electroporation (IRE) is a novel ablative treatment, which aims to provide local tumor control. The aim of this study was to examine how consolidative treatment with IRE affects quality of life (QOL) and pain perception (PP) in patients with non-metastatic pancreatic cancer. METHODS: Secondary outcomes were extracted from a prospective cohort of non-metastatic PC patients treated with IRE from 2013 to 2019...
May 5, 2021: Pancreatology: Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
https://read.qxmd.com/read/33920118/irreversible-electroporation-ire-in-locally-advanced-pancreatic-cancer-a-review-of-current-clinical-outcomes-mechanism-of-action-and-opportunities-for-synergistic-therapy
#18
REVIEW
Zainab L Rai, Roger Feakins, Laura J Pallett, Derek Manas, Brian R Davidson
Locally advanced pancreatic cancer (LAPC) accounts for 30% of patients with pancreatic cancer. Irreversible electroporation (IRE) is a novel cancer treatment that may improve survival and quality of life in LAPC. This narrative review will provide a perspective on the clinical experience of pancreas IRE therapy, explore the evidence for the mode of action, assess treatment complications, and propose strategies for augmenting IRE response. A systematic search was performed using PubMed regarding the clinical use and safety profile of IRE on pancreatic cancer, post-IRE sequential histological changes, associated immune response, and synergistic therapies...
April 10, 2021: Journal of Clinical Medicine
https://read.qxmd.com/read/33906911/conversion-of-%C3%AE-cells-to-%C3%AE-cells-in-the-postpartum-mouse-pancreas-involves-lgr5-progeny
#19
JOURNAL ARTICLE
Uylissa A Rodriguez, Mairobys Socorro, Angela Criscimanna, Christina P Martins, Nada Mohamed, Jing Hu, Krishna Prasadan, George K Gittes, Farzad Esni
In contrast to the skin and the gut, where somatic stem cells and their niche are well characterized, a definitive pancreatic multipotent cell population in the adult pancreas has yet to be revealed. Of particular interest is whether such cells may be endogenous in patients with diabetes, and if so, can they be used for therapeutic purposes? In the current study, we used two separate reporter lines to target Cre-recombinase expression to the Lgr5- or glucagon-expressing cells in the pancreas. We provide evidence for the existence of a population of cells within and in the proximity of the ducts that transiently express the stem-cell marker Lgr5 during late gestational stages...
July 2021: Diabetes
https://read.qxmd.com/read/33891997/cadmium-induces-endoplasmic-reticulum-stress-mediated-apoptosis-in-pig-pancreas-via-the-increase-of-th1-cells
#20
JOURNAL ARTICLE
Hao Wu, Shufang Zheng, Jinxi Zhang, Shiwen Xu, Zhiruo Miao
Cadmium (Cd), an environmental pollutant, causes several adverse reactions in animals. High dose of Cd has serious cytotoxicities, including the induction of programmed cell necrosis, autophagy and apoptosis, which has aroused wide public concern. The balance of cytokine network is affected by Th1/Th2 balance which is closely related to immune response and the occurrence, development, treatment and outcome of various diseases. Cd can induce severe apoptosis, but the relationship between Cd induced apoptosis and Th1/Th2 balance has not been clarified...
April 20, 2021: Toxicology
keyword
keyword
39855
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.